1. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin;Sliwkowski;J Biol Chem,1994
2. The erbB3 gene product is a recetor for heregulin;Carraway;J Biol Chem,1994
3. Pertuzumab and its accelerated approval: evolving treatment paradigms and new challenges in the management of HER2-positive breast cancer;O'Sullivan;Oncol (Williston Park),2014
4. Afatinib: first global approval;Dungo;Drugs,2013
5. Understanding the mechanisms behind trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer;Spector;J Clin Oncol,2009